|
HMGN4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.681400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.799000E-01 |
| Normal-vs-Stage2 |
6.101800E-01 |
| Normal-vs-Stage3 |
9.085200E-01 |
| Normal-vs-Stage4 |
3.172400E-01 |
| Stage1-vs-Stage2 |
7.503000E-01 |
| Stage1-vs-Stage3 |
8.888000E-01 |
| Stage1-vs-Stage4 |
4.593600E-01 |
| Stage2-vs-Stage3 |
7.088600E-01 |
| Stage2-vs-Stage4 |
6.625800E-01 |
| Stage3-vs-Stage4 |
4.182000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.365000E-01 |
| Normal-vs-AfricanAmerican |
2.045400E-01 |
| Normal-vs-Asian |
5.901600E-01 |
| Caucasian-vs-AfricanAmerican |
1.818780E-01 |
| Caucasian-vs-Asian |
7.492000E-01 |
| AfricanAmerican-vs-Asian |
8.801000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.941600E-01 |
| Normal-vs-Female |
1.280640E-01 |
| Male-vs-Female |
1.821850E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.334400E-01 |
| Normal-vs-Extreme_Weight |
8.737200E-01 |
| Normal-vs-Obese |
3.642600E-01 |
| Normal-vs-Extreme_Obese |
3.116800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.819400E-01 |
| Normal_Weight-vs-Obese |
3.652000E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.199400E-01 |
| Extreme_Weight-vs-Obese |
1.665800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
3.635200E-01 |
| Obese-vs-Extreme_Obese |
1.430800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.025610E-01 |
| Normal-vs-Age(41-60Yrs) |
2.480400E-01 |
| Normal-vs-Age(61-80Yrs) |
9.325200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.529400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.160400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.482830E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.121900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.180780E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.292500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.567600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.242800E-01 |
| Normal-VS-Type2 PRCC |
3.979000E-01 |
| Normal-VS-KIRP CIMP |
1.071830E-01 |
| Normal-VS-Unclassified PRCC |
8.585800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.077600E-03 |
| Type1 PRCC-VS-KIRP CIMP |
3.689200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.998000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.878300E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.980000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.611600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.101200E-01 |
| Normal-vs-N1 |
8.286400E-02 |
| Normal-vs-N2 |
1.814620E-01 |
| N0-vs-N1 |
3.155300E-03 |
| N0-vs-N2 |
3.965000E-01 |
| N1-vs-N2 |
7.594100E-02 |
|
|
